Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[AIDS and blood transfusion].

K Baumgarten1

  • 1Blutspendezentrale des Osterr. Roten Kreuzes, Wien.

Zeitschrift Fur Hautkrankheiten
|July 1, 1990
PubMed
Summary
This summary is machine-generated.

Routine HIV 1 antibody screening of blood donors in Vienna identified 59 positive cases by 1989. A follow-up study investigated potential transmission from repeat donors before screening began.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Placement of covered self-expanding metal stent to treat razor blade-induced esophageal hemorrhage.

Endoscopy·2010
Same author

[Jonas and Lukas].

Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege·2003
Same author

The plasma membrane-associated protein RS1 decreases transcription of the transporter SGLT1 in confluent LLC-PK1 cells.

The Journal of biological chemistry·2001
Same author

The transport modifier RS1 is localized at the inner side of the plasma membrane and changes membrane capacitance.

Biochimica et biophysica acta·2000
Same author

Financial impact of a home intravenous antibiotic program on a medicare managed care program.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2000
Same author

Transport of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard (D-19575) into tumor cells is mediated by the Na+-D-glucose cotransporter SAAT1.

Proceedings of the National Academy of Sciences of the United States of America·1998

Area of Science:

  • Infectious Diseases
  • Public Health
  • Virology

Context:

  • Routine human immunodeficiency virus type 1 (HIV-1) antibody screening commenced in May 1985 at the Red Cross Blood Donation Center in Vienna, Lower Austria, and Burgenland.
  • By summer 1989, approximately 750,000 blood donors and donations were screened, identifying 59 HIV-1 positive donors.
  • A follow-up study was initiated due to the presence of repeat donors who had donated for years prior to the screening implementation.

Purpose:

  • To investigate the potential transmission of HIV-1 from repeat donors to recipients before routine screening was established.
  • To evaluate the results of HIV-1 antigen screening in approximately 200,000 donors.
  • To report on the screening of 80,000 donors for anti-HIV-1 and anti-HIV-2 antibodies and discuss the implications of questionable positive western blot results.

Related Experiment Videos

Summary:

  • Screening of 750,000 blood donors between May 1985 and summer 1989 identified 59 HIV-1 positive individuals.
  • A follow-up study explored transmission risks from repeat donors prior to May 1985.
  • HIV-1 antigen screening of 200,000 donors and HIV-1 and HIV-2 antibody screening of 80,000 donors were conducted, with no HIV-2 cases found.

Impact:

  • The study highlights the importance of donor screening in preventing transfusion-transmitted infections.
  • It addresses the challenges in interpreting borderline western blot results and the ethical considerations of informing donors.
  • Findings contribute to understanding HIV transmission dynamics in blood donation settings and inform public health strategies.